Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Robust estimation of protein expression ratios with lysate microarray technology.

Cristian Mircean1, Ilya Shmulevich, David Cogdell

  • 1Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, USA.

Bioinformatics (Oxford, England)
|January 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perspectives From an Expert-Guided Discussion on Maximizing the Research Potential of Small Biopsy Tissue.

JCO precision oncology·2026
Same author

Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I.

JCO precision oncology·2026
Same author

Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer.

Nature communications·2026
Same author

Larotrectinib in Patients With Tumors With <i>NTRK</i> Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E.

JCO precision oncology·2026
Same author

Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF</i><sup><i>V600E</i></sup> Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H.

JCO precision oncology·2026

Developing robust algorithms for protein lysate microarrays improves quantification accuracy. A robust least squares estimator algorithm offers the most precise measurement of relative protein expression levels from serially diluted samples.

Area of Science:

  • Proteomics
  • Bioinformatics
  • Biotechnology

Background:

  • Protein lysate microarrays are an emerging technology for high-throughput protein expression analysis.
  • Accurate quantification is challenging due to the limited dynamic range of chromogenic detection systems.
  • Serial dilutions and triplicate spotting are used to capture measurements across a wider dynamic range.

Purpose of the Study:

  • To develop and evaluate algorithms for accurate quantification of relative protein expression from protein lysate microarray data.
  • To address the challenge of limited dynamic range in protein expression measurements.
  • To provide reliable methods for analyzing multiple data points from serially diluted samples.

Main Methods:

  • Cross-validation was employed to assess algorithm performance.

Related Experiment Videos

  • A 1440-spot microarray with purified bovine serum albumin (BSA) in triplicate and six 2-fold dilutions was created for evaluation.
  • The robust least squares estimator algorithm was compared against other methods.

    • Main Results:

    • The algorithm based on a robust least squares estimator demonstrated the most accurate quantification of protein lysate microarray data.
    • The developed methods were successfully applied to estimate relative expression levels of p53 and p21 in HCT116 colon cancer cells.
    • The study included drug treatments and their combinations, showcasing the algorithm's applicability in complex biological contexts.

    Conclusions:

    • The robust least squares estimator algorithm is highly effective for accurate relative protein quantification on lysate microarrays.
    • This algorithmic approach enhances the reliability of proteomic data analysis, particularly when dealing with limited dynamic range.
    • The validated methods offer a significant advancement for researchers studying protein expression in various biological samples and conditions.